Fermiscan Holdings Limited is listed on the Australian Securities Exchange (ASX:FER) and is building an international business specialising in early detection technologies for improved health outcomes. There are two major businesses: the Fermiscan Test which is the commercialisation of a world first non-invasive and simple breast cancer screening for women of all ages and the Sydney Breast Clinic, a leading provider of diagnostic assessments and breast screening for over 30 years.
Service : IRM Corporate Website Visit Site : http://www.fermiscanltd.com.au/ |
![]() |
To find out how we can assist your company improve its online investor communications, please contact us on
+61 2 82563341 or email .